All Releases
 |
ARYx to Present at Cowen and Company Annual Health Care Conference
Mar 4, 2010
|
9.9 KB |
|
| |
FREMONT, Calif., Mar 04, 2010 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced that it will
present at the Cowen and Company 30th Annual Health Care
Conference in Boston on March 9, 2010 at 1:30 pm Eastern. A live Webcast
of the presentation may be accessed at the ARYx Website http://www.aryx.com.
...
|
|
ARYx Therapeutics Retains Cowen and Company To Explore Strategic Options
Feb 18, 2010
|
12.2 KB |
|
| |
FREMONT, Calif., Feb 18, 2010 (BUSINESS WIRE) -- ARYx Therapeutics Inc. (NASDAQ: ARYX), a biopharmaceutical company,
today announced that it has retained Cowen and Company to explore
strategic options for ARYx. While discussions continue with
pharmaceutical companies regarding the licensing of its oral
antiarrythmic ...
|
|
ARYx Therapeutics Receives Guidance on Anticoagulant Agent Tecarfarin
Jan 5, 2010
|
15.0 KB |
|
| |
FREMONT, Calif., Jan 05, 2010 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company,
today announced that is has received guidance in writing from the U.S.
Food and Drug Administration (FDA) confirming that the existing
development pathway remains acceptable to seek regulatory approval of
...
|
|
Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association
Nov 18, 2009
|
13.4 KB |
|
| |
FREMONT, Calif., Nov 18, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company,
announced that a review of the results of the Phase 2b clinical trial,
PASCAL, testing the efficacy and safety of ARYx's compound for the
treatment of atrial fibrillation, budiodarone, was presented today at
...
|
|
ARYx Therapeutics Reports Third Quarter 2009 Results
Nov 12, 2009
|
22.0 KB |
|
| |
FREMONT, Calif., Nov 12, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of
operations and provided a general business update for the third quarter
ended September 30, 2009.
"Our highest priority remains completing a partnership with a large
pharmaceutical company on our oral antiarrythm...
|
|
ARYx Therapeutics Schedules Third Quarter 2009 Results Conference Call
Nov 5, 2009
|
9.9 KB |
|
| |
FREMONT, Calif., Nov 05, 2009 (BUSINESS WIRE) -- ARYx Therapeutics Inc (NASDAQ:ARYX), a biopharmaceutical company,
announced today that a conference call to discuss third quarter 2009
results and to provide a general business update will be held on
Thursday, November 12, 2009 at 8:00 a.m. Pacific Time.
The dial-in informati...
|
|
ARYx to Present at the Oppenheimer Annual Healthcare Conference
Oct 30, 2009
|
10.2 KB |
|
| |
FREMONT, Calif., Oct 30, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced that it will
present at the Oppenheimer 20th Annual Healthcare Conference
in New York on November 4, 2009 at 10:15 am Eastern. A live Webcast of
the presentation, together with the presentation slides, may be accessed
...
|
|
ARYx Therapeutics Aligns Operations to Development Activities
Oct 29, 2009
|
13.4 KB |
|
| |
FREMONT, Calif., Oct 29, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company,
today announced that it has implemented a staffing plan to operate the
company that anticipates licensing its lead development programs and
resuming development of earlier stage product candidates. ARYx expect...
|
|
ARYx Therapeutics Secures $35 Million Committed Equity Financing Facility
Oct 7, 2009
|
12.6 KB |
|
| |
FREMONT, Calif., Oct 07, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company,
today announced that it has secured a committed equity financing
facility under which it may sell up to $35 million of shares of its
common stock to Commerce Court Small Cap Value Fund, Ltd. ("Commerce
...
|
|
ARYx to Present at the Morgan Stanley Global Healthcare Conference
Sep 9, 2009
|
9.5 KB |
|
| |
FREMONT, Calif., Sep 09, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced that it will
present at the Morgan Stanley Global Healthcare Unplugged Conference on
September 14, 2009 in New York. A live Webcast of the presentation may
be accessed at the ARYx Website http://www.aryx.com.
The pr...
|
|
ARYx Therapeutics Reports Second Quarter 2009 Results
Aug 13, 2009
|
21.9 KB |
|
| |
FREMONT, Calif., Aug 13, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of
operations and provided a general business update for the second quarter
ended June 30, 2009.
"During the second quarter, we completed the Phase 2/3 EmbraceAC
clinical trial comparing tecarfarin, ARYx's novel ora...
|
|
ARYx Therapeutics Schedules Second Quarter 2009 Results Conference Call
Aug 5, 2009
|
9.8 KB |
|
| |
FREMONT, Calif., Aug 05, 2009 (BUSINESS WIRE) -- ARYx Therapeutics Inc (NASDAQ:ARYX), a biopharmaceutical company,
announced today that a conference call to discuss second quarter 2009
results and to provide a general business update will be held on
Thursday, August 13, 2009 at 8:00 a.m. Pacific Time.
The dial-in informatio...
|
|
ARYx Therapeutics Announces Results of Phase 2/3 Clinical Trial on Anticoagulant Agent Tecarfarin
Jul 7, 2009
|
22.2 KB |
|
| |
FREMONT, Calif., Jul 07, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company,
today announced results from its Phase 2/3 clinical trial, EmbraceAC,
comparing its novel anticoagulant agent tecarfarin (previously ATI-5923)
with the leading oral anticoagulant warfarin. In this trial, tecar...
|
|
ARYx Therapeutics Inc. Updates Progress with Tecarfarin EmbraceAC Study
Jun 16, 2009
|
14.0 KB |
|
| |
FREMONT, Calif., Jun 16, 2009 (BUSINESS WIRE) -- ARYx Therapeutics Inc. (NASDAQ:ARYX), a biopharmaceutical company,
announced today that the database for the EmbraceAC study has been
locked and the study remains on schedule, with the efficacy and safety
results to be available during the week of July 6, 2009. The study was
...
|
|
ARYx to Present at the Jefferies 3rd Annual Healthcare Conference
Jun 10, 2009
|
9.5 KB |
|
| |
FREMONT, Calif., Jun 10, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced that it will
present at the Jefferies & Company 3rd Annual Healthcare Conference on
Wednesday, June 17, 2009 at 2:45 p.m. Eastern Time. A live webcast of
the presentation may be accessed at the ARYx website http://www.aryx....
|
|
ARYx Reports First Quarter 2009 Results and Earnings
May 14, 2009
|
19.0 KB |
|
| |
FREMONT, Calif., May 14, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of
operations and provided an update on its products for the first quarter
ended March 31, 2009.
"During the first quarter, we remained on track with all of our lead
programs in order to meet our existing clinical a...
|
|
ARYx Therapeutics Schedules First Quarter 2009 Results and Earnings Call
May 7, 2009
|
9.7 KB |
|
| |
FREMONT, Calif., May 07, 2009 (BUSINESS WIRE) -- ARYx Therapeutics Inc (NASDAQ:ARYX), a biopharmaceutical company,
announced today that a conference call to discuss first quarter 2009
results will be held on Thursday, May 14, 2009 at 8:00 a.m. Pacific Time.
The dial-in information for the call is as follows:
Dial In: 877-741-4241
...
|
|
ARYx Reports Fourth Quarter and Full Year 2008 Results of Operations
Mar 26, 2009
|
21.1 KB |
|
| |
FREMONT, Calif., Mar 26, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of
operations and provided an update on its products for the fourth quarter
and year ended December 31, 2008.
"2008 was an eventful and productive year for ARYx, as we have now
generated proof of concept for each of...
|
|
ARYx Therapeutics Schedules Fourth Quarter and Year End 2008 Results and Earnings Call
Mar 19, 2009
|
9.7 KB |
|
| |
FREMONT, Calif., Mar 19, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company,
announced today that a conference call to discuss fourth quarter and
year end 2008 results will be held on Thursday, March 26, 2009 at 8:00
a.m. Pacific Time.
The dial-in information for the call is as follow...
|
|
ARYx to Present at the Cowen and Company 29th Annual Healthcare Conference
Mar 13, 2009
|
9.5 KB |
|
| |
FREMONT, Calif., Mar 13, 2009 (BUSINESS WIRE) -- ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced that it will
present at the Cowen and Company 29th Annual Healthcare
Conference Monday, March 16 at 4:40 p.m. Eastern Time. A live webcast of
the presentation may be accessed at the ARYx website http://www.aryx.com.
...
|
|
|
Print page 
Email page 
Shareholder Briefcase
Printed Materials
Download Library
RSS News Feeds
